115 related articles for article (PubMed ID: 20108418)
1. Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, Duchenne.
Dasouki M; Barohn R; Hegde M
Hum Genet; 2010 Jan; 127(1):109. PubMed ID: 20108418
[No Abstract] [Full Text] [Related]
2. Novel human pathological mutations. Gene symbol: DMD. Disease: muscular dystrophy, Duchenne.
Garcia-Planells J; Torres-Puente M; Vilchez JJ; Pérez-Alonso M
Hum Genet; 2009 Aug; 126(2):338. PubMed ID: 19694016
[No Abstract] [Full Text] [Related]
3. Novel human pathological mutations. Gene symbol: DMD. Disease: muscular dystrophy, Duchenne.
Garcia-Planells J; Torres-Puente M; Vilchez JJ; Perez-Alonso M
Hum Genet; 2009 Aug; 126(2):338. PubMed ID: 19694014
[No Abstract] [Full Text] [Related]
4. Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, Duchenne.
Dasouki M; Barohn R; Zhu H
Hum Genet; 2010 Jan; 127(1):109. PubMed ID: 19898871
[No Abstract] [Full Text] [Related]
5. Gene symbol: DMD. Disease: Muscular dystrophy, Duchenne.
Dasouki M; Barohn R
Hum Genet; 2008 Oct; 124(3):321. PubMed ID: 18846679
[No Abstract] [Full Text] [Related]
6. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
7. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
[TBL] [Abstract][Full Text] [Related]
8. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
Kerr TP; Sewry CA; Robb SA; Roberts RG
Hum Genet; 2001 Oct; 109(4):402-7. PubMed ID: 11702221
[TBL] [Abstract][Full Text] [Related]
9. [Genotype-phenotype discordance in a Duchenne muscular dystrophy patient due to a novel mutation: insights into the shock absorber function of dystrophin].
López-Hernández LB; van Heusden D; Soriano-Ursúa MA; Figuera-Villanueva L; Vázquez-Cárdenas NA; Canto P; Gómez-Díaz B; Coral-Vázquez RM
Rev Neurol; 2011 Jun; 52(12):720-4. PubMed ID: 21594857
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy.
Katayama Y; Tran VK; Hoan NT; Zhang Z; Goji K; Yagi M; Takeshima Y; Saiki K; Nhan NT; Matsuo M
Hum Genet; 2006 Jun; 119(5):516-9. PubMed ID: 16528518
[TBL] [Abstract][Full Text] [Related]
12. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families.
Elhawary NA; Shawky RM; Hashem N
Mol Cells; 2004 Oct; 18(2):141-9. PubMed ID: 15528988
[TBL] [Abstract][Full Text] [Related]
13. Point mutations in Czech DMD/BMD patients and their phenotypic outcome.
Sedlácková J; Vondrácek P; Hermanová M; Zámecník J; Hrubá Z; Haberlová J; Kraus J; Maríková T; Hedvicáková P; Vohánka S; Fajkusová L
Neuromuscul Disord; 2009 Nov; 19(11):749-53. PubMed ID: 19783145
[TBL] [Abstract][Full Text] [Related]
14. Paternal inheritance or a de novo mutation in a Duchenne Muscular Dystrophy pedigree from South India.
Purushottam M; Murthy AR; Shubha GN; Gayathri N; Nalini A
J Neurol Sci; 2008 May; 268(1-2):179-82. PubMed ID: 18031759
[TBL] [Abstract][Full Text] [Related]
15. Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide.
Buzin CH; Feng J; Yan J; Scaringe W; Liu Q; den Dunnen J; Mendell JR; Sommer SS
Hum Mutat; 2005 Feb; 25(2):177-88. PubMed ID: 15643612
[TBL] [Abstract][Full Text] [Related]
16. [Identification of disease-causing point mutations in DMD patients' dystrophin gene without large deletions/duplications].
Shen BC; Zhang C; Chen SL; Sun XF; Li SY; Yao XL; Wang SH; Lu XL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):392-6. PubMed ID: 16883524
[TBL] [Abstract][Full Text] [Related]
17. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre.
Tuffery-Giraud S; Saquet C; Chambert S; Echenne B; Marie Cuisset J; Rivier F; Cossée M; Philippe C; Monnier N; Bieth E; Recan D; Antoinette Voelckel M; Perelman S; Lambert JC; Malcolm S; Claustres M
Neuromuscul Disord; 2004 Oct; 14(10):650-8. PubMed ID: 15351422
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum leading to an attenuated phenotype in dystrophinopathies.
Tuffery-Giraud S; Saquet C; Thorel D; Disset A; Rivier F; Malcolm S; Claustres M
Eur J Hum Genet; 2005 Dec; 13(12):1254-60. PubMed ID: 16077730
[TBL] [Abstract][Full Text] [Related]
20. Loss of a single amino acid from dystrophin resulting in Duchenne muscular dystrophy with retention of dystrophin protein.
Becker K; Robb SA; Hatton Z; Yau SC; Abbs S; Roberts RG
Hum Mutat; 2003 Jun; 21(6):651. PubMed ID: 14961551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]